Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PrairieCare is a leading mental healthcare provider with a full commercial continuum of evidence-based services including acute inpatient, residential, partial hospitalization, intensive outpatient, and clinic-based care for all ages. Programs are tailored for disorders like depression, anxiety, bipolar disorder, eating and substance use disorders, and more. Clinical services include psychotherapy (CBT, DBT), psychiatry, medication management, specialty therapies (e.g., art, recreational), and advanced device-based therapies such as transcranial magnetic stimulation (TMS). In 2022, PrairieCare was acquired by Newport Healthcare, further supporting its mission and expanding clinical offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PrairieCare.